Form Health Hidden Fees: What the $299/Month Rate Excludes in 2026

Last reviewed: September 17, 2026 Last updated: September 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Form Health's advertised $299/month self-pay rate covers obesity-medicine physician access, dietitian access, and messaging support, but it does not include medication or lab work. Those two line items—which together typically represent the majority of monthly weight-loss spending—are billed separately. The total monthly cost therefore depends on which FDA-approved medication your physician prescribes (Wegovy, Zepbound, or Saxenda), your insurance coverage or pharmacy discount, and the frequency and scope of required lab panels. Form Health does not publish medication or lab pricing, so prospective patients cannot calculate a true all-in monthly figure before intake. In contrast, all-inclusive telehealth programs bundle medication, clinician oversight, and shipping into a single fixed monthly fee; PlexusDx, for example, charges $189/month for compounded semaglutide injection or $289/month for compounded tirzepatide injection with no separate medication, lab, or membership charges.

What Form Health's $299/month includes—and what it doesn't

Form Health operates an FDA-approved-medication-only obesity-medicine practice staffed by physicians and dietitians. On the self-pay track, patients pay $299 per month (verified September 4, 2026, formhealth.co/faqs). That monthly subscription covers:

• Physician access — consultations and prescription management by an obesity-medicine physician.
• Dietitian access — nutritional counseling and behavioral support.
• Messaging support — asynchronous communication with the care team.

The $299 fee does not include:

• Medications — Wegovy (semaglutide), Zepbound (tirzepatide), Saxenda (liraglutide), or other FDA-approved drugs prescribed by the physician are billed separately. Form Health does not publish medication pricing; cost depends on the patient's insurance plan, pharmacy benefit, or manufacturer discount card.
• Labs — Baseline and follow-up lab panels (typically metabolic panels, lipid panels, and sometimes thyroid or liver function tests) are ordered as clinically indicated and billed separately. Form Health does not publish lab pricing or frequency requirements.

Because medication and lab costs are unbundled and unpublished, a prospective patient cannot determine the true monthly outlay before starting the program.

Source: formhealth.co/faqs, captured September 4, 2026.

Estimating the true monthly cost

To arrive at a realistic monthly budget, patients must add medication and lab expenses to the $299 service fee. Neither figure is published by Form Health, so we rely on typical market ranges:

Medication costs (FDA-approved, self-pay or discount-card rates)

• Wegovy (semaglutide): List price approximately $1,300–1,600/month; manufacturer savings card can reduce cost to $0–550/month depending on insurance status and eligibility. Without insurance or discount, self-pay may exceed $1,000/month.
• Zepbound (tirzepatide): List price approximately $1,000–1,200/month; Eli Lilly savings program can reduce cost to $550/month for eligible commercial-insurance patients or $650/month for self-pay patients meeting income criteria. Without discounts, self-pay may approach $1,000/month.
• Saxenda (liraglutide): List price approximately $1,400/month; savings-card programs exist but out-of-pocket cost varies widely.

Patients with comprehensive insurance coverage may pay only copay tier costs (often $25–100/month), but many commercial plans do not cover obesity medications, and Medicare Part D generally excludes weight-loss drugs.

Lab costs

• A comprehensive metabolic panel, lipid panel, and thyroid/liver function tests typically cost $100–300 when ordered through a retail lab (Quest, LabCorp) without insurance.
• Frequency varies by protocol; initial labs plus follow-ups every 3–6 months is common. Amortized over 12 months, lab costs may add $10–50/month.

Illustrative 12-month scenarios (our calculations)

Scenario A: Patient with manufacturer discount card for Wegovy, reducing drug cost to $300/month

• Service fee: $299/month × 12 = $3,588
• Medication: $300/month × 12 = $3,600
• Labs (estimated): $200 × 3 panels = $600
• Total 12-month cost: $7,788 ($649/month average)

Scenario B: Self-pay patient, no discount card, Zepbound at $1,000/month

• Service fee: $299/month × 12 = $3,588
• Medication: $1,000/month × 12 = $12,000
• Labs (estimated): $600
• Total 12-month cost: $16,188 ($1,349/month average)

Scenario C: Commercial insurance covers medication with $50 copay

• Service fee: $299/month × 12 = $3,588
• Medication: $50/month × 12 = $600
• Labs (estimated, insurance may cover): $200
• Total 12-month cost: $4,388 ($366/month average)

All three scenarios are speculative because Form Health does not publish medication or lab pricing, and actual cost depends on insurance status, drug tier, and discount-program eligibility. Prospective patients should request a personalized cost estimate during the intake process.

All-inclusive alternatives: PlexusDx and the compounded-medication model

A separate category of telehealth providers dispenses compounded GLP-1 medications—custom-prepared semaglutide or tirzepatide made by licensed compounding pharmacies—and bundles medication, clinician oversight, and shipping into a single monthly fee. PlexusDx is one such program.

PlexusDx all-in pricing (month-to-month plans)

• Compounded semaglutide injection: $189/month (3-month plan $169/month prepaid, 6-month plan $149/month prepaid)
• Compounded tirzepatide injection: $289/month (3-month plan $269/month prepaid, 6-month plan $249/month prepaid)
• No membership fee, no separate medication charge, no separate lab fee, no separate shipping fee.
• Same price at every dose.

Over 12 months on the month-to-month plan:

• Semaglutide injection: $189 × 12 = $2,268 total (medication + clinician + shipping included)
• Tirzepatide injection: $289 × 12 = $3,468 total (medication + clinician + shipping included)

Figures verified September 17, 2026, from PlexusDx product pages.

Compounded vs FDA-approved medications

Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

FDA-approved medications—Wegovy, Zepbound, Saxenda—undergo rigorous premarket review for safety and efficacy and carry standardized dosing, manufacturing controls, and pharmacovigilance. They are typically preferred when insurance covers the cost or when a patient has a clinical or personal preference for brand-name drugs. Compounded medications may be appropriate when FDA-approved options are cost-prohibitive, on shortage, or when a patient and clinician agree that a compounded formulation meets the treatment goal.

Form Health figures from formhealth.co/faqs, captured September 4, 2026. PlexusDx figures verified September 17, 2026. The 12-month estimate range for Form Health reflects scenario calculations above and is not an official Form Health quote.

Decision factors: service model, medication category, and cost predictability

When Form Health's unbundled structure may make sense

• Insurance covers FDA-approved drugs: If your commercial plan covers Wegovy or Zepbound with a manageable copay ($25–100/month), Form Health's $299 service fee plus copay may be less expensive than an all-in compounded program, and you receive FDA-approved medication with established regulatory oversight.
• Preference for FDA-approved medications: Some patients and clinicians prefer brand-name drugs with premarket approval and standardized manufacturing.
• Dietitian support is a priority: Form Health includes structured dietitian access in the base fee; many compounded-medication telehealth programs do not offer dedicated dietitian support or charge separately for it.

When Form Health's structure may be a disadvantage

• No insurance or high out-of-pocket drug costs: If you are self-pay or your insurance does not cover obesity medications, the combined $299 service fee plus $300–1,000+/month medication cost can exceed $600/month—more than double the cost of an all-in compounded program.
• Unpredictable budgeting: Because medication and lab costs are unbundled and unpublished, you cannot finalize a monthly budget until after intake and prescription. Patients who prefer fixed, transparent monthly pricing may find the uncertainty frustrating.
• Lab-fee opacity: Lab panel costs and ordering frequency are not disclosed upfront, creating another variable expense.

Choose Form Health if…

• Your insurance plan covers Wegovy, Zepbound, or Saxenda with a reasonable copay, making the total monthly outlay (copay + $299) competitive with all-in programs.
• You have a clinical or personal preference for FDA-approved medications and are willing to accept higher cost in exchange for regulatory approval and brand-name assurance.
• You value integrated dietitian support and physician oversight within a single care team, and the $299 monthly service fee is acceptable even before medication costs.
• You are comfortable budgeting for variable medication and lab expenses and can request a personalized cost estimate during intake.

Choose an all-in compounded program (PlexusDx or similar) if…

• You are self-pay or your insurance does not cover obesity medications, and you want the lowest fixed monthly cost with medication included.
• Predictable, transparent pricing is a priority—you want to know the exact monthly charge before you start, with no separate medication or lab bills.
• You and your clinician agree that compounded semaglutide or tirzepatide is appropriate for your treatment goals, and you accept that compounded drugs are not FDA-approved.
• You prefer a streamlined care model focused on medication management and clinician messaging, without separate dietitian services (or you are willing to source nutrition counseling separately).

Where PlexusDx fits

PlexusDx operates an all-inclusive compounded GLP-1 program with fixed monthly pricing: $189/month for semaglutide injection or $289/month for tirzepatide injection (month-to-month plans; 3-month and 6-month prepaid plans offer lower per-month rates). Every plan includes medication, licensed clinician oversight, and shipping—no membership fees, no separate medication charges, no hidden lab bills. The same price applies at every dose, so monthly costs remain constant as your clinician titrates your prescription. PlexusDx works with licensed 503A compounding pharmacies.

Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

Methodology and freshness

Form Health pricing and service-model facts were captured September 4, 2026, from the company's public FAQ page (formhealth.co/faqs). PlexusDx pricing was verified September 17, 2026, from live product pages. The 12-month cost scenarios for Form Health are our calculations, combining the published $299/month service fee with estimated medication and lab costs drawn from typical market ranges for FDA-approved GLP-1 drugs and retail lab panels. Form Health does not publish medication or lab pricing; prospective patients should request a personalized cost estimate during intake. Trustpilot ratings for PlexusDx were captured September 9, 2026. All prices are in U.S. dollars and reflect self-pay rates; insurance-covered costs vary by plan. This comparison was published September 17, 2026, and will be refreshed when new pricing or service-model information becomes available.

Frequently Asked Questions

Does Form Health's $299/month include medication?

No. Form Health's $299/month self-pay fee covers physician access, dietitian access, and messaging support, but medication is billed separately. The program prescribes FDA-approved drugs (Wegovy, Zepbound, Saxenda), and cost depends on your insurance, pharmacy benefit, or manufacturer discount card. Form Health does not publish medication pricing.

Does Form Health charge separately for labs?

Yes. Baseline and follow-up lab panels are ordered as clinically indicated and billed separately. Form Health does not publish lab costs or the required frequency of testing, so total lab expense over 12 months is unknown until you start the program and your physician orders the panels.

Can I get a fixed all-in monthly price that includes medication?

Form Health operates an unbundled service model, so medication and labs are separate line items. If you prefer predictable all-in pricing, consider telehealth programs that dispense compounded GLP-1 medications with medication included in a single monthly fee—such as PlexusDx at $189/month for semaglutide or $289/month for tirzepatide, with no separate charges.

What is the difference between FDA-approved and compounded GLP-1 medications?

FDA-approved drugs (Wegovy, Zepbound, Saxenda) undergo premarket review for safety, efficacy, and manufacturing quality and carry standardized dosing. Compounded medications are custom-prepared by licensed pharmacies and are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before marketing. A licensed clinician decides which option is appropriate based on your clinical picture, insurance status, and cost.

How much do Wegovy and Zepbound cost without insurance?

Wegovy's list price is approximately $1,300–1,600/month; Zepbound's is approximately $1,000–1,200/month. Manufacturer savings programs can reduce costs to $0–650/month for eligible patients, depending on insurance status and income. Without insurance or discount cards, self-pay costs often exceed $1,000/month. Actual price depends on pharmacy, dose, and discount-program qualification.

Sources

• Form Health Frequently Asked Questions, https://www.formhealth.co/faqs (accessed September 4, 2026)
• PlexusDx product pages (semaglutide injection, tirzepatide injection), https://plexusdx.com (accessed September 17, 2026)
• Trustpilot review profile for PlexusDx, https://www.trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• U.S. Food and Drug Administration, "Compounded Drugs: Questions and Answers," fda.gov (general reference)

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.